![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 32, 22393-22400, August 6, 1999
,
,
,
,
, and
**
From the
Department of Molecular Medicine,
Section of Biochemistry, Molecular and Cell Biology, Cornell
University, Ithaca, New York 14853-6401, § Onyx
Pharmaceuticals, Richmond, California 94806, and the
¶ Department of Medicine, Duke University Medical Center,
Durham, North Carolina 27710
| |
ABSTRACT |
|---|
|
|
|---|
The p21-activated kinases (Pak) are major targets
of the small GTPases Cdc42 and Rac. We, and others, recently identified a family of proteins termed Cool/Pix, which interact with Pak3. In
cells, p50Cool-1 suppresses Pak activation by
upstream activators; p85Cool-1 has a permissive effect on
Pak activation, and we now show that the closely related Cool-2
stimulates Pak kinase activity. To understand the differential
regulation of Pak by Cool proteins, we screened for Cool-interacting
proteins by affinity purification and microsequencing. This has led to
the identification of two closely related proteins called Cat
(Cool-associated, tyrosine phosphorylated), which contain a zinc finger followed by three ankyrin
repeats. Cat-1 is identical to the recently identified binding partner
for the The GTP-binding proteins Cdc42 and Rac initiate signaling pathways
that impact on cell cycle progression and influence cell shape and the
actin cytoskeleton (1-6). Among the best known targets of these
GTP-binding proteins are the p21-activated serine/threonine kinases
(Paks)1 (7, 8). At present,
there are three closely related members of the family (Pak1-3) and a
recently discovered but less closely related member named Pak4 (9). The
mammalian Paks are homologous to the Saccharomyces
cerevisiae Ste20 protein kinase, which plays an essential role in
the pheromone/mating factor pathway by regulating a protein kinase
cascade that leads to the nucleus and stimulates the mitogen-activated
protein kinases FUS3/KSS1 (10). It was subsequently appreciated that
both Cdc42 and Rac also initiate signaling cascades to the nucleus that
involve activation of the stress responsive mitogen-activated protein
kinases, c-Jun kinase, and p38 (11-14) and that in some situations,
this signaling is mediated via Cdc42/Rac-stimulation of Pak activity
(13, 15).
Pak has been implicated as an important mediator in triggering actin
cytoskeletal and cell morphological changes (16-21). In some cases, it
appears that Pak activation antagonizes RhoA-mediated signaling,
resulting in dissolution of actin stress fibers and a decrease in the
formation of focal complexes (17). It has also been reported that the
overexpression of Pak leads to actin cytoskeletal rearrangements, which
do not depend on its kinase activity (16), and that Pak is essential
for neurite extension in rat adrenal PC12 cells (19). Recently it has
been shown that Pak is required for cell transformation by Ras (22) and
that phosphorylation of Raf-1 by Pak may play an important role in Ras-mediated transformation (23). Paks may therefore function as
critical control proteins for a variety of Cdc42- and Rac-stimulated cellular responses making it likely that they are tightly regulated both in terms of their activity and cellular localization. Recent developments are consistent with an intricate regulation of the Paks,
because a family of Pak-binding proteins named Cool (cloned out of library; Ref. 24), Pix
(Pak-interacting exchange factor; Ref. 25), or p85SPR (SH3 domain containing, proline-rich;
Ref. 26) has been identified. These proteins share tandem SH3, Dbl
homology, and pleckstrin homology domains and associate with Paks via
their SH3 domain. The presence of the Dbl homology domain implied a
guanine nucleotide exchange factor (GEF) activity for the Cool
proteins, which by directly activating Cdc42 and/or Rac would activate
Pak. p85Cool-1 (identical to In the present work, we describe the identification and
characterization of a family of proteins that bind to the
carboxyl-terminal region of p85Cool-1 and do not bind to
p50Cool-1. One of these is a 95-kDa protein that is
tyrosine-phosphorylated in vivo and therefore has been
designated Cat-1 (Cool-associated, tyrosine phosphorylated). A second highly related gene
product, Mr ~85 kDa, was cloned and named
Cat-2. In addition to their specific binding to p85Cool-1,
both Cat-1 and Cat-2 are also capable of binding to the
carboxyl-terminal domain of Cool-2 (identical to Cloning of Cat-2 cDNA--
Based on peptide microsequencing
results, oligonucleotides 5'-GATGCAGTCTGGCTTGCCACG-3' and
5'-TCGTGTTGATGAGTACGCAGG-3' corresponding to DAVWLAT and PEYSSTR,
respectively, encoded by the human KIAA0148 gene were used to amplify a
96-bp PCR product from a lambda ZAP HeLa cDNA library (Stratagene).
The PCR product was subcloned into PCR2.1 (Invitrogen) and sequenced
using an automated sequencer (Applied Biosystems). A lambda ZAP mouse
NIH 3T3 cDNA phage library (Stratagene) was screened with the 96-bp
PCR product labeled by randomly priming with
[ Cloning of Cool-2--
Cool-2 was cloned from a human
hippocampus lambda ZAP cDNA library (Stratagene) using a probe
containing nucleotides 658-1324 that were generated using primers
based on the GenBankTM D23304 sequence.
Plasmid Construction--
Full-length Cat-2 was cloned into the
BamHI site of hemagglutinin (HA)- or Myc-tagged
pcDNA3.1Ack-2 or a Myc-tagged pcDNA3 vector as an ~2480-bp
insert. Full-length Cool-2 was cloned into the XbaI and
PleI/SmaI sites in the Myc-tagged vector J3M as
an ~2500-bp insert. Cool-2 from the J3M vector was also subcloned into the XbaI/EcoRI sites of the Myc-tagged
pcDNA3 vector. The COOH-terminal domain of Cool-1 spanning amino
acids 369-649 was amplified by PCR and cloned as a
BamHI-EcoRI fragment into Myc-tagged pcDNA3.
The plasmid expressing COOH-terminal Flag-tagged rat Git-1 (G protein-coupled receptor kinase
interactor-1) has been described previously
(27). Plasmids expressing p50Cool-1, p85Cool-1,
p85(W43K) Cool-1, and Dbl have all been described (24). The Dbl
homology domain of p85Cool-1 spanning amino acids 83-290
was amplified by PCR and subcloned as a
BamHI-EcoRI fragment into the Myc-tagged CMVM6
vector. A cDNA fragment encoding amino acids 148-238 of Pak3 was
amplified by PCR and subcloned into the
BamHI-SalI site of the pGEX-KG plasmid to express
the Cool-binding domain (CBD). Amino acids 537-666 of Cool-2 were
amplified by PCR and subcloned into the
BamHI-EcoRI site of plasmid pGEX-KG. The triple
HA-tagged Fak, the kinase-defective HA-Fak (K454R), and HA-Fak(Y397F)
expression plasmids have been described previously (28). The HA-Tiam-1
expression plasmid was a generous gift from Dr. Frits Michiels (The
Netherland Cancer Institute, Netherlands).
Protein Expression--
GST-Cdc42, GST-Cdc42(Q61L), GST-CBD, and
GST-Cool-2-(537-666) fusion proteins were expressed in
Escherichia coli and purified by glutathione-agarose
affinity chromatography (29). LipofectAMINE-mediated transient
transfections of COS or 3T3 cells were performed according to the
manufacturer's protocol (Life Technologies, Inc). Cells were lysed
36-48 h after the addition of DNA.
Cell Lysis, Kinase Assays, and Immunoprecipitations--
Cells
were washed with cold phosphate-buffered saline, lysed in lysis buffer
A (20 mM Hepes, pH 7.4, 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA, 1 mM sodium
vanadate, 10 µg/ml leupeptin, and 10 µg/ml aprotinin) with 20 mM Mitotic Cells and Cell Adhesion--
NIH 3T3 cells were grown in
DMEM (Life Technologies, Inc.) containing 10% calf serum. 1 × 106 cells were plated/100-mm dish 18-24 h prior to adding
nocodazole (0.1 µg/ml). After 14 h of nocodazole treatment,
mitotic cells were collected by shake-off. Cells were released from
mitosis by washing twice with DMEM, plated in DMEM plus 10% calf serum on tissue culture plates, and lysed after 60 or 90 min. For cell adhesion, NIH 3T3 cells were serum-starved in DMEM containing 0.5%
calf serum for 18-24 h. Starved cells were trypsinized for 1-2 min,
washed with DMEM containing 0.5 mg/ml trypsin inhibitor (Sigma),
resuspended in DMEM, and added to plates coated with either bovine
serum albumin (2 mg/ml), fibronectin (10 µg/ml), or polylysine (10 µg/ml) for different time points. Tissue culture plates were treated
with fibronectin or polylysine for 16 h at 4 °C. Plates were
then washed with phosphate-buffered saline (3×) and additionally
treated with heat-denatured bovine serum albumin (2 mg/ml) in
phosphate-buffered saline at 37 °C for 2 h.
Cool-2 Activates Pak--
We have previously shown that a novel
Pak3 binding partner, named p50Cool-1 (cloned
out of library), inhibits Pak3
activity and its stimulation by upstream activators. A larger splice
variant designated p85Cool-1, which is identical to A Tyrosine-phosphorylated 95-kDa Protein Co-precipitates with Cool
and Pak3--
Our first clue to the existence of a cellular protein
that binds specifically to p85Cool-1 or Cool-2, but not
p50Cool-1, came from biochemical studies aimed at
identifying Pak3-associated proteins. As shown in Fig.
2A, we initially noticed a
tyrosine-phosphorylated ~95-kDa protein that co-immunoprecipitated
with Pak3 from NIH 3T3 cell lysates (lane 6). A
tyrosine-phosphorylated protein of identical mass was also detected
when cell lysates were affinity precipitated with a GTPase-defective,
constitutively active Cdc42 mutant, GST-Cdc42(Q61L) (Fig.
2A, lane 4) but not when lysates were incubated
with GST-Cdc42(GDP) (lane 3). Thus, the 95-kDa tyrosine-phosphorylated protein (originally designated p95) appeared to
associate with GST-Cdc42, perhaps via its association with Pak3.
To delineate the region on Pak3 that was responsible for its
association with p95, different GST-Pak3 fusion proteins were prepared
and used as affinity reagents. A GST fusion protein that contained
amino acid residues 148-238 of Pak3 was able to affinity precipitate
the tyrosine-phosphorylated p95 from NIH 3T3 cell lysates (Fig.
2A, lane 5). We refer to this region on Pak3 as the CBD, because we have found that it is sufficient for binding the
Cool proteins. The fact that the CBD was essential for the association
of p95 raised the possibility that p95 may bind indirectly to Pak3 via
Cool. This was further suggested when we were able to
co-immunoprecipitate p95 with Cool from NIH 3T3 cells using an
anti-Cool antibody (Fig. 2B, lane 1). We were not
able to detect endogenous Pak in the anti-Cool immunoprecipitates
(possibly because there is less Pak than Cool or p95 in NIH 3T3 cells
and/or because the Cool antibody interferes with the Pak3-binding site
on Cool). Therefore, co-precipitation of p95 with Cool-1 could not be
attributed to a p95-Pak interaction, but most likely reflected a
direct interaction between p95 and Cool.
We next set out to establish that the tyrosine-phosphorylated p95 that
co-immunoprecipitated with Cool was identical to the 95-kDa protein
that co-immunoprecipitated with Pak-3, as well as affinity precipitated
with GST-CBD. The serial depletion of tyrosine-phosphorylated p95 from
Src(Y527F)-transformed NIH 3T3 cell lysates resulted in a decrease in
the amount of tyrosine-phosphorylated p95 associated with GST-CBD (Fig.
2C, lanes 1-3) and in the amount of p95
associated with GST-Cool-2 (residues 537-666) (lane 4 where p95 was depleted from lysates versus lane 5 where it was not
depleted). These data argue that the tyrosine-phosphorylated p95 that
associated with Pak3 and GST-CBD was identical to the 95-kDa
phosphoprotein that bound to GST-Cool-2 (residues 537-666). Because
p95 was a Cool-associated and
tyrosine-phosphorylated protein, we refer to it as Cat-1.
It should be noted that the ability of Cat-1 to associate with
activated Cdc42 (Fig. 2A, lane 4) is
apparently through a quaternary Cdc42-Pak3-Cool-Cat complex.
Identification of Mouse p95Cat-1 as Git-1 and Molecular
Cloning of a Related Protein, Cat-2--
Using GST-CBD as an affinity
reagent, we set out to purify Cat-1 from Src(Y527F)-transformed cells,
which can be grown to high density and appeared to contain relatively
large amounts of the tyrosine-phosphorylated p95Cat
protein. Silver staining revealed two major bands of
Mr ~86 and 95 kDa that were co-precipitated
with GST-CBD (Fig. 3A,
lanes 2 and 3). The protein band at ~86 kDa is
p85Cool-1, as determined by microsequence analysis. Three
peptides obtained from microsequencing of the 95-kDa protein were
identical to a recently identified protein designated Git-1, which was
discovered based on its ability to bind the
Blast sequence analysis showed that like Cat-1, the Cat-2 protein has a
Gcs-type (33) C2C2H2 zinc finger motif (amino acids 11-44), which is
part of a larger conserved domain (amino acids 3-77), and a triple
ankyrin repeat region (amino acids 126-226) (Fig. 3C). Both
Cat-1 and Cat-2 also show sequence similarity to ASAP1, a
phospholipid-dependent Arf-GAP that associates with and is
phosphorylated by Src (34), mammalian Arf-GAP1 (35), and yeast Gcs1
(36), as well as sharing homology with the tumor suppressor BRCA
1-associated ring domain protein, BARD1 (accession number 495973), the
phosphatidylinositol 1,4,5-triphosphate-binding protein, centaurin-
Both Cat-1 and Cat-2 bind to p85Cool-1 in mammalian cells.
This was shown by transiently co-expressing Flag-tagged Cat-1 or
HA-Cat-2 with Myc-tagged Pak3, Myc-p50Cool-1,
Myc-p85Cool-1, or Myc-p85(W43K Cool-1) (an SH3 domain point
mutant that is defective in binding Pak3 (24)) and then assaying for
complex formation by co-immunoprecipitation and Western blot analysis (Fig. 4). Flag-Cat-1 (Fig. 4A)
and HA-Cat-2 (Fig. 4, B and C) were each detected
in anti-Myc p85Cool-1 and p85Cool-2
immunoprecipitates (Fig. 4A, lanes 1 and
2; Fig. 4B, lane 3; and Fig. 4C, lanes
3 and 4) and did not associate with Pak3 (Fig. 4B, lane 1) or p50Cool-1 (Fig.
4B, lane 2). The Cat/Cool interactions are not
dependent on the SH3 domain of Cool, as p85Cool-1
point-mutated in the SH3 domain still interacts with both Cat-1 (Fig.
4A, lane 5) and Cat-2 (Fig. 4B,
lane 4). The interactions between the Cat and Cool molecules
must involve the carboxyl-terminal domains of p85Cool-1 or
p85Cool-2, because p50Cool-1, which does not
bind the Cat proteins, is otherwise identical to p85Cool-1.
As shown in Fig. 4, A and C, amino acid residues
369-649 of p85Cool-1 are sufficient for binding
Flag-tagged Cat-1 (lane 3) and HA-tagged Cat-2 (lane
5).
Cell Cycle and Cell Adhesion-dependent Regulation of
Tyrosine Phosphorylation of p95--
Given that the Paks and their
upstream activators, Cdc42 and Rac, have been implicated in the
regulation of cell cycle progression (1, 38-41), we were interested in
examining the tyrosine phosphorylation of Cat-1 during the cell cycle
(Fig. 5). We expressed Flag-tagged Cat-1
in NIH 3T3 cells, arrested the transfected cells in mitosis by
nocodazole treatment, and analyzed tyrosine phosphorylation of Cat-1 in
anti-Flag immunoprecipitates by anti-phosphotyrosine immunoblotting
(Fig. 5A). Consistent with our results with endogenous p95,
we found that Cat-1 was tyrosine phosphorylated in unsynchronized NIH
3T3 cells (lane 2). However, phosphotyrosine was not
detectable in Cat-1 immunoprecipitated from mitotic cells (lane
3) indicating that Cat-1 was tyrosine dephosphorylated when cells
were in mitosis. When cells were released from mitotic arrest, Cat-1
was again phosphorylated on tyrosine (lane 4). These results
were consistent with those obtained when examining the tyrosine
phosphorylation of endogenous p95. Tyrosine-phosphorylated p95 was
affinity precipitated by GST-CBD and co-immunoprecipitated with Cool
from unsynchronized NIH 3T3 cell lysates (Fig. 5C,
lanes 4 and 7). However, in cells arrested in
mitosis (Fig. 5B, middle panel),
tyrosine-phosphorylated p95 was not detected in either GST-CBD affinity
precipitates (Fig. 5C, lane 5) or in anti-Cool
immunoprecipitates (lane 8). When cells were released from
mitosis, a rapid reappearance (within 1 h) of
tyrosine-phosphorylated p95 in GST-CBD affinity precipitates and
anti-Cool immunoprecipitates (lanes 6 and 9) was
detected.
The reappearance of tyrosine-phosphorylated p95 correlated with the
readherence and spreading of the early G1 cells to the substratum (Fig. 5B, right panel). We therefore
examined whether tyrosine phosphorylation of Cat-1 was dependent on
cell adhesion. NIH 3T3 cells were trypsinized and replated on plates
coated with fibronectin, polylysine, or bovine serum albumin, and
tyrosine phosphorylation of endogenous p95 was analyzed in GST-CBD
affinity precipitates (Fig.
6A). Tyrosine phosphorylation
of p95 was detectable only after plating on fibronectin (lane
5). Tyrosine phosphorylation was induced within 15 min of plating
on fibronectin and continued to increase when cells were plated for up
to 1 h (Fig. 6B, lanes 6-8).
These results suggested that tyrosine phosphorylation of Cat-1 may
occur via integrin-mediated signaling pathways, which led us to examine
the possibility that Cat-1 and/or Cat-2 might be phosphorylated by
tyrosine kinases that have been implicated in integrin signaling (Fig.
7). COS cells were co-transfected with Myc-tagged Cat-2 and wild-type HA-tagged Fak, kinase-defective HA-Fak(K454R), or HA-Fak mutated at an autophosphorylation site (Y397F), and then immunoprecipitated Cat-2 was analyzed by Western blotting with antiphosphotyrosine (Fig. 7A).
Tyrosine-phosphorylated Cat-2 was not detected in control cells
(transfected with vector alone, lane 2); however, tyrosine
phosphorylation of Cat-2 was readily detectable in cells expressing
wild-type Fak (lane 3). A decrease in the levels of tyrosine
phosphorylation of Cat-2 was observed in the presence of either kinase
defective-Fak or Y397F-mutant Fak (lanes 4 and
5). The fact that the Cat protein still showed detectable
tyrosine phosphorylation in cells expressing kinase-defective Fak
suggests that an additional kinase(s) is involved. One possibility is
Src, because autophosphorylated Tyr-397 of Fak serves as a docking site
for Src family tyrosine kinases and may mediate Src activation and
recruitment to focal adhesions (42). We have examined the tyrosine
phosphorylation of FLAG-tagged Cat-1 in Src-transformed NIH 3T3 cells
(Fig. 7B) and found that tyrosine phosphorylation of Cat-1
was significantly increased compared with normal NIH 3T3 cells
(lanes 2 and 4). Thus, the tyrosine
phosphorylation of Cat that accompanies the exit of cells from mitosis
into G1 and adherence to fibronectin is likely to involve
both the Fak and Src tyrosine kinases. These results, taken together
with the recent finding that Cat-2/Pk1 has paxillin binding capability
(45), raise some interesting possibilities regarding a role for the Cat
proteins in interfacing integrin signaling with Pak activation
(43).
Paks participate in a diversity of biological responses including
regulation of actin cytoskeleton changes and signaling pathways that
underly cellular stress responses and impact on cell growth (7, 8,
17-19, 21, 44). This implies that the Paks will be subject to a
variety of regulatory mechanisms. At present, the best understood
mechanism involves the binding of activated, GTP-bound forms of Cdc42
and Rac to an amino-terminal domain within Pak (p21-binding domain),
which de-represses an intramolecular inhibitory interaction and
increases access to the Pak active site. More recently, a new family of
regulatory molecules have been identified, Cool/Pix, whose members bind
to Paks 1 and 3 at a proline-rich sequence downstream from the
p21-binding domain (24, 25). The Pix proteins were proposed to recruit
and activate Rac, which in turn could stimulate the bound Pak (25).
However, recent studies with the Cool proteins (p85Cool-1
is identical to A particularly interesting aspect of Cool function is that although
p50Cool-1, p85Cool-1, and p85Cool-2
all appear to bind to an identical region on Pak such that they compete
with each other for binding, the larger Cool proteins are not
inhibitory, and in fact Cool-2 stimulates Pak kinase activity. Inhibition of Pak activity by p50Cool-1 appears to be
competitive, possibly by blocking access of substrates, including Pak
autophosphorylation sites. Because p85Cool-1 and
p85Cool-2, which both have an extended COOH terminus
downstream of the SH3/Dbl homology/pleckstrin homology domain, do not
inhibit Pak, it is possible that these larger Cool proteins are
conformationally distinct from p50Cool-1 when bound to Pak.
The most likely possibility for these functional differences between
the different Cool molecules is that a protein(s) binds to the extended
carboxyl-terminal domains of p85Cool-1 and
p85Cool-2 and maintains these Cool molecules in an optimal
orientation for supporting activation, rather than inhibition, of Pak activity.
We have now identified two proteins that bind to the carboxyl-terminal
domains of p85Cool-1 and p85Cool-2 but do not
bind to p50Cool-1 and thus are candidates for playing a
role in Pak regulation. One of these proteins is a
tyrosine-phosphorylated protein, Cat-1, which is identical to Git-1, a
recently identified A particularly interesting possibility is that the Cats serve as
important control points for mediating integrin- and cell cycle-dependent regulation of Pak. We have found that the
tyrosine phosphorylation of Cat-1 is decreased in mitotic cells but
increased early in the following G1 phase and upon cell
adhesion to a fibronectin matrix. The Cats may be involved in
recruiting Pak-Cool complexes to cellular sites for integrin signaling
such as focal adhesions. This would be consistent with the paxillin
binding capability of Cat-2/Pk1. It has also recently been reported
that Pak activity is stimulated following cell adhesion (43), so it is
attractive to consider that this occurs via a Cat-Cool-Pak signaling
complex in which Cat maintains Cool in an appropriate conformation for a stimulatory rather than inhibitory signal to Pak. We were able to
show that Cat-1 and Cat-2 are tyrosine phosphorylated after co-expression with activated Src or Fak. Although we do not know whether either of these tyrosine kinases directly phosphorylates Cat-1
or Cat-2 in cells, it is tempting to speculate that Cat-1 may couple
Fak/Src tyrosine kinase signaling pathways to Pak serine/threonine kinase pathways. Interestingly another protein possessing an Arf-GAP zinc finger domain/ankyrin repeat motif, ASAP1, has recently been shown
to be a direct target of activated Src (34).
Thus far, we have been unable to detect significant stimulation of Pak3
kinase activity following co-expression of Cat-1 or Cat-2 with
Pak3.3 This may mean that Cat proteins are not limiting in
the cell. However, it may also suggest that additional signals,
possibly from integrin or cell cycle signaling pathways, are needed to promote Cat- and Cool-mediated Pak activation. Because Paks have been
shown to be involved in terminal cellular events such as transformation
and apoptosis, it is not surprising that Pak activity is tightly
regulated and that its activation may require multiple inputs. The Cat
proteins are likely to play important roles in integrating these
signals to appropriately regulate Pak activity. Future efforts will be
devoted to identifying dominant-negative Cat mutants that can be used
to block Pak activation and thereby help delineate the different
signaling pathways responsible for Pak regulation.
-adrenergic receptor kinase (
ARK or GRK-2), which was
shown to have Arf-GAP activity. Cat-1 and Cat-2 both bind to the
COOH-terminal region of p85Cool-1 and p85Cool-2
but do not bind to p50Cool-1. Cat-1 is
tyrosine-phosphorylated in growing NIH 3T3 fibroblasts, and its
tyrosine phosphorylation is increased following cell spreading on
fibronectin, decreased in cells arrested in mitosis, and increased in
the ensuing G1 phase. Cat proteins are
tyrosine-phosphorylated when co-expressed in cells with the focal
adhesion kinase Fak and Src. These findings suggest that in addition to
playing a role in Cool/Pak interactions, Cat proteins may serve
as points of convergence between G protein-coupled receptors,
integrins, Arf GTPases, cell cycle regulators, and Cdc42/Rac/Pak
signaling pathways.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Pix and
p85SPR) has been shown to have weak (25) or undetectable
(24) exchange factor activity against Rac1 and no detectable activity
against Cdc42 (24, 25). This suggests that either the exchange factor activities of Cool proteins are tightly regulated or that their mechanism of action does not involve exchange factor activity. This
possibility is supported by the observation that p50Cool-1,
a splice variant of p85Cool-1 that contains the presumptive
exchange factor domain, inhibits rather than activates Pak (24).
p85Cool-1 does not inhibit Pak activity but rather has a
permissive effect on the stimulation of Pak by the GEF Dbl (24). The
differences in the functional outcomes of the binding of
p50Cool-1 and p85Cool-1 to an identical site on
the Paks suggest that the extended carboxyl-terminal region of
p85Cool-1 might prevent it from competitively inhibiting
Pak autophosphorylation and phosphorylation of substrates.
-Pix), a member of
the Cool/Pix/p85SPR family that unlike Cool-1 activates
Pak3 when the two proteins are co-expressed in cells. The abilities of
the Cat proteins to selectively bind to Cool proteins, which promote
rather than repress Pak activity, as well as our finding that Cat is
tyrosine phosphorylated in a cell adhesion and cell
cycle-dependent manner, suggest that Cool-Cat complexes may
play key roles in Pak regulation.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]dCTP (Prime-gene kit, Stratagene). Eight
positive plaques were purified, and the excised cDNA inserts were
partially sequenced. Several clones contained sequences related to the
KIAA0148 gene. The longest clone (~2100 bp) was sequenced and
determined to lack the 5'-end. The 5'-end of Cat-2 containing the
initiation ATG (~400 bp) was cloned by 5'-rapid amplification of
cDNA ends (Life Technologies) from mouse brain poly(A) RNA
(CLONTECH).
-glycerophosphate, and 5% glycerol and lysates were
centrifuged at 12,000 × g for 25 min at 4 °C. For
kinase assays, lysates were frozen in liquid nitrogen and stored at
80 °C. The amount of Pak3 in the lysates was first determined by
Western blotting an aliquot prior to immunoprecipitation. Lysates
containing equal amounts of Pak3 were immunoprecipitated with anti-Pak3
primary antibody (a gift from Dr. S. Pelech, Kinetek Biotechnology
Corp., Vancouver, Canada) for 1-2 h followed by incubation with
protein A-Sepharose for 1 h. Immunoprecipitates were washed three
times with buffer A and once with 2× kinase buffer (40 mM
Hepes, pH 7.4, 20 mM MgCl2, and 4 mM MnCl2) and mixed with 5 µg of myelin basic
protein (Sigma). Kinase reactions were initiated by the addition of
kinase buffer and 20 µM [
-32P]ATP (3000 Ci/mmol) for 3.5 min at room temperature. Reactions were stopped by the
addition of 2× SDS sample buffer containing 20 mM EDTA.
Proteins eluted by boiling for 2 min were separated by 12.5%
SDS-polyacrylamide gel electrophoresis. Proteins were transferred to
Immobilon P membranes (Millipore) and autoradiographed prior to
immunoblotting. Blots were stained with Amido Black, and bands
corresponding to myelin basic protein were excised and subjected to
Cherenkov counting. Blots were probed with anti-HA (12CA5 (ascites) or
CA-11 (Babco)), anti-Myc (ascites), anti-FLAG M2 (Santa Cruz
Biotechnology), anti-Cool (24), anti-PTyr (4G10, UBI), or anti-Pak3
antibodies, and the primary antibodies were detected with horseradish
peroxidase-coupled sheep anti-mouse or donkey anti-rabbit
antibody by ECL (Amersham Pharmacia Biotech).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Pix
(25), competes with p50Cool-1 for binding to Pak3 but is
not inhibitory and instead has a permissive effect on Pak3 activity
(24). A related gene product, which we named Cool-2 and is identical to
-Pix (24, 25), also competes with p50Cool-1 for binding
Pak3; however, it stimulates rather than inhibits Pak3 activity. These
data are presented in Fig. 1. In this
experiment, Pak3 was co-expressed with the different Cool proteins or
with other members of the Dbl family, in COS cells. Pak3 was then
precipitated, and its ability to phosphorylate exogenous substrates was
assayed using myelin basic protein. In the absence of a stimulatory
factor (e.g. activated Cdc42 or Rac), p50Cool-1
had no detectable effect on myelin basic protein phosphorylation, whereas p85Cool-1 showed a modest (<2-fold) stimulation.
However, like Dbl, Tiam-1 and Vav, which have been shown to act as
guanine nucleotide exchange factors for Cdc42 or Rac (30-32) and
thereby activate Cdc42/Rac-targets (e.g. Pak3),
co-expression of Cool-2 with Pak3 also significantly stimulated Pak3
activity. These findings raise the question of why Cool-2 is able to
bind and stimulate Pak3 activity or in the case of
p85Cool-1 permissively support Pak3 activity, whereas
p50Cool-1 acts as a competitive inhibitor of
autophosphorylation and substrate phosphorylation. We reasoned that the
extended carboxyl terminus present within p85Cool-1 and
p85Cool-2, relative to p50Cool-1, may allow a
protein-binding interaction that prevents these Cool molecules from
blocking access to the protein kinase active site of Pak3. Thus, we set
out to identify a binding partner that was capable of associating with
p85Cool-1 and/or p85Cool-2 but not
p50Cool-1.

View larger version (40K):
[in a new window]
Fig. 1.
Cool-2 activates Pak3. COS cells were
co-transfected with plasmids expressing the indicated proteins. Pak3
was immunoprecipitated with anti-Pak3 polyclonal antibody and Pak
kinase activity was measured in an immune complex kinase assay using
myelin basic protein (MBP) as substrate. The levels of Pak3
in the immunoprecipitates (IP) were essentially equivalent
as shown by the anti-Pak3 Western blot. DH, Dbl
homology.

View larger version (24K):
[in a new window]
Fig. 2.
A 95-kDa tyrosine-phosphorylated protein
co-purifies with Cool and Pak3. A, NIH 3T3 cell lysates
were incubated with GST, GST-Cdc42, GST-Cdc42(Q61L), GST-CBD, anti-Pak3
polyclonal antibody, or without antibody (Ab) (lanes
2-8, respectively) and precipitated with glutathione-Sepharose or
protein A-Sepharose beads. Bound proteins were washed, separated by
SDS-polyacrylamide gel electrophoresis, Western blotted, and probed
with anti-phosphotyrosine antibody 4G10 (UBI). Wcl, whole
cell lystates. B, whole cell lysates from NIH 3T3
fibroblasts were incubated with either anti-Cool polyclonal antibody
(lane 1) or protein A-Sepharose alone (lane 2).
Bound proteins were processed as in A. C, cell
lysates from NIH 3T3 cells overexpressing Src (Y527F) were incubated
with GST-CBD for 2 h and then precipitated (lane 1);
the supernatant from lane 1 was reincubated with fresh
GST-CBD for an additional 2 h and then precipitated (lane
2), and the supernatant from lane 2 was reincubated
with fresh GST-CBD for 1 h and then precipitated (lane
3). GST-Cool-2 (residues 537-666) was incubated with either the
depleted supernatant from lane 3 (lane 4) or with
nondepleted lysate (lane 5). Bound proteins were detected by
Western blotting with anti-phosphotyrosine antibody 4G10 (UBI).
-adrenergic receptor
kinase (GRK-2) (27). The same three peptides obtained from the 95-kDa protein also showed close matches with an ~50-kDa human protein of
unknown function, KIAA0148 (peptide 1, 15/15 identity; peptide 2, 16/18
identity; peptide 3, 13/16 identity, 15/16 similarity). We also
identified an additional related protein through molecular cloning,
using oligonucleotides derived from the KIAA0148 sequence to screen an
NIH 3T3 cDNA library. We isolated a full-length clone that encodes
a protein of 708 amino acids that we termed Cat-2 (Fig. 3B).
As shown below, both Cat-1 and Cat-2 are Cool-binding proteins. Cat-2
appears to be 81% identical and 87% similar to a paxillin-binding
protein designated paxillin kinase linker (Pkl) (45), and Cat-2 is 69%
identical and 78% similar to rat Git-1 and 86% identical and 89%
similar to human KIAA0148. In summary, we believe that Cat-1 is the
mouse homolog of rat Git-1 and that Cat-2 is an alternatively spliced
homolog of human Pk1 and KIAA0148. Both Cat-1 and Cat-2 are widely
distributed in a variety of tissues including heart, brain, and
skeletal muscle (data not shown).

View larger version (46K):
[in a new window]
Fig. 3.
Purification and molecular cloning of
Cat. A, cell lysates from Src (Y527F)-transformed cells
(527) or lysis buffer alone (LB) were affinity precipitated
with GST-CBD (lanes 1-3) or GST alone (lane 4).
Bound proteins were separated by SDS-polyacrylamide gel electrophoresis
and detected by silver staining. The positions of p95 and molecular
mass standards are indicated. B, schematic representation
and amino acid sequence of mouse Cat-2. The coding sequence of Cat-2
contains a zinc finger region (residues 3-77) containing the motif
CXXCX16CXXC, where X is any
amino acid (residues 11-44) and three ankyrin repeat regions (residues
126-226). Amino acid sequence alignment was done using the Jotun Hein
cluster method. Peptides 1-3, obtained from microsequencing of p95,
were identical to residues 152-166, 352-370, and 371-386 in Git-1,
respectively. Mouse Cat-2 is 69 and 86% identical to the amino acid
sequence of rat Git-1 and human KIAA0148, respectively.
(37), and several proteins of unknown function in the data base. So
far, Arf-GAP, Git-1, and ASAP1 have been shown to have Arf-GAP activity
(27, 34, 35). p95Cat-1 and p95Cat-2 also
contain a number of potential SH3-binding sites (PXXP).

View larger version (21K):
[in a new window]
Fig. 4.
Cat proteins associate with Cool in
cells. A, COS cells were transiently transfected with
plasmids expressing the indicated Myc-tagged proteins (lanes
1-3, 5) or empty vector alone with a plasmid
expressing FLAG-tagged Cat-1/Git-1. Anti-Myc (9E10) immunoprecipitates
(IP) were probed with either anti-FLAG (M2) or anti-Myc
antibody. Cool-1 (369-649) expresses the COOH-terminal 280 amino acids
of p85Cool-1. B, COS cells were transiently
transfected with plasmids expressing the indicated Myc-tagged proteins
along with HA-tagged Cat-2. Anti-Myc immunoprecipitates were Western
blotted with anti-HA or anti-Myc. A portion of the whole cell lysate
(WCL) was Western blotted with anti-HA to show expression of
HA-Cat-2. C, COS cells were transiently transfected with
plasmids expressing the indicated Myc-tagged proteins along with
HA-Cat-2. Anti-Myc immunoprecipitates were Western blotted with
anti-HA. A portion of the whole cell lysate was Western blotted with
anti-Myc.

View larger version (58K):
[in a new window]
Fig. 5.
Cell cycle-dependent Cat-1
tyrosine phosphorylation. A, NIH 3T3 cells were
transiently transfected with FLAG-tagged Cat-1/Git-1; cells were then
trypsinized and replated. Unsynchronized cells (U), cells
arrested in mitosis with nocodazole (M), or cells released
from nocodazole block for 90 min (MR) were lysed, and
FLAG-tagged Cat-1/Git-1 was immunoprecipitated with an anti-FLAG M2
monoclonal antibody or lysates from unsynchronized cells were incubated
with protein G-Sepharose alone (lane 1). Immunoprecipitates
(IP) were Western blotted with either anti-phosphotyrosine
or with anti-FLAG antibody. B, the panels show
unsynchronized NIH 3T3 cells, cells arrested in mitosis by nocodazole,
and cells released from a nocodazole block for 1 h. Mitotic cells
are round and loosely attached to the plate and respread within 1 h of release. C, NIH 3T3 cell lysates from unsynchronized
(U), mitotic (M), or cells released from the
nocodazole block (MR) were incubated with GST-CBD or
anti-Cool polyclonal antibody as indicated. Bound proteins were Western
blotted with either anti-phosphotyrosine antibody 4G10, (lanes
1-9) or anti-Cool antibody (lanes 4-9). Lanes
1-3 represent a fraction of the whole cell lysate
(wcl) used in the binding reaction.

View larger version (30K):
[in a new window]
Fig. 6.
Stimulation of p95 tyrosine phosphorylation
after cell spreading on fibronectin. A, serum-starved
NIH 3T3 cells were trypsinized and replated on plates coated with
bovine serum albumin (B), fibronectin (F), or
poly-L-lysine (P) for 1 h. Cells were lysed
and affinity precipitated with GST-CBD. Whole cell lysates
(wcl) and proteins affinity precipitated with GST-CBD were
detected by Western blotting with antiphosphotyrosine. B,
serum-starved NIH 3T3 were trypsinized and replated on
fibronectin-coated plates for 15, 30, or 60 min or on bovine serum
albumin coated plates for 60 min and processed as in
A.

View larger version (33K):
[in a new window]
Fig. 7.
Cat proteins are tyrosine phosphorylated by
Fak and Src. COS cells were transiently transfected with
Myc-tagged Cat-2 or co-transfected with HA-tagged wild type
(WT), kinase-defective (KD), or the
autophosphorylation site-mutated (Y397F) Fak as indicated.
Anti-Myc immunoprecipitates (IP) were Western blotted with
anti-Myc or anti-phosphotyrosine antibody. A portion of the whole cell
lysate (wcl) was Western blotted with anti-HA to show Fak
expression. B, NIH 3T3 or Src (Y527F)-transformed NIH 3T3
cells were transiently transfected with FLAG-Cat-1/Git-1. Anti-FLAG
immunoprecipitates (IP) were Western blotted with
anti-phosphotyrosine or anti-FLAG antibody (Ab).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Pix, and Cool-2 is identical to
-Pix) suggest that more complex regulatory mechanisms may be in place. Although it
was reported that the Pix proteins are capable of GEF activity (25),
thus far we have not been able to convincingly show that p85Cool-1 or p85Cool-2 directly stimulates the
nucleotide exchange activity of Rac or Cdc42 in vitro; we
have also failed to detect a GEF activity for the Cool proteins in
cellular assays of Cdc42/Rac activation under conditions where the well
characterized GEFs for Cdc42 and/or Rac, Dbl, Tiam-1, and Vav all
showed GEF activity (24).2 These findings
raise the possibility that p85Cool-1 and
p85Cool-2 may act as cofactors to support the activation of
Pak by GTP-bound Cdc42 or Rac, rather than stimulating Pak activity by
directly activating these GTP-binding proteins. Moreover,
p50Cool-1 inhibits rather than stimulates Pak activity,
suggesting that the Cool proteins may also act as direct allosteric
regulators of Pak.
ARK-associated protein (27). Cat-2 is a homolog
of a recently identified paxillin-binding protein (Pkl) (45). Both
Cat-1 and Cat-2 contain a putative zinc finger domain that shares
similarity with mammalian and yeast proteins shown to possess Arf-GAP
activity and indeed Git-1 is an Arf-GAP (27). Thus, in addition to
playing a regulatory role in Cool/Pak interactions, the Cats are likely
to serve as points of convergence for a diversity of signaling
molecules including integrins, heterotrimeric G protein-coupled
receptors, Arf, and Cdc42/Rac.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Frits Michiels for the HA-Tiam-1 plasmid, Dr. Takahiro Nagase for his generous gift of the KIAA0148 cDNA clone HA3431, Drs. Robert J. Lefkowitz, Wannian Yang, and Jihe Zhao for helpful discussions, and Drs. Chris Turner and Michael Brown for sharing unpublished results. We also thank Cindy Westmiller for expert secretarial assistance.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants GM40654 and GM47458 and by a grant from the Human Frontiers of Science Program (to R. A. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed. Tel.: 607-253-3650; Fax: 607-253-3659.
2 S. Bagrodia, D. Bailey, Z. Lenard, M. Hart, J. L. Guan, R. T. Premont, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Pak, p21-activated kinase; SH, Src homology; GEF, guanine nucleotide exchange factor; bp, base pair(s); PCR, polymerase chain reaction; HA, hemagluttinin; CBD, Cool-binding domain; GST, glutathione S- transferase; DMEM, Dulbecco's modified Eagle's medium.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Olson, M. F.,
Ashworth, A.,
and Hall, A.
(1995)
Science
269,
1270-1272 |
| 2. | Ridley, A. J., and Hall, A. (1992) Cell 70, 389-399[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Kozma, R., Ahmed, S., Best, A., and Lim, L. (1995) Mol. Cell. Biol. 15, 1942-1952[Abstract] |
| 4. | Nobes, C. D., and Hall, A. (1995) Cell 81, 53-62[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Van-Aelst, L.,
and DíSouza-Schorey, C.
(1997)
Genes Dev.
11,
2295-2322 |
| 6. |
Hall, A.
(1998)
Science
279,
509-514 |
| 7. | Sells, M. A., and Chernoff, J. (1997) Trends Cell Biol. 7, 162-167 |
| 8. | Lim, L., Manser, E., Leung, T., and Hall, C. (1996) Eur. J. Biochem. 242, 171-185[Medline] [Order article via Infotrieve] |
| 9. | Abo, A., Qu, J., Cammarano, M. S., Dan, C., Fritsch, A., Baud, V., Belisle, B., and Minden, A. (1998) EMBO J. 17, 6527-6540[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Herskowitz, I. (1995) Cell 80, 187-197[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Minden, A.,
Lin, A.,
McMahon, M.,
Lange-Carter, C.,
Derijard, B.,
Davis, R. J.,
Johnson, G. L.,
and Karin, M.
(1994)
Science
266,
1719-1723 |
| 12. | Coso, O. A., Chiariello, M., Yu, J.-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. (1995) Cell 81, 1137-1146[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Bagrodia, S.,
Derijard, B.,
Davis, R. J.,
and Cerione, R. A.
(1995)
J. Biol. Chem.
270,
27995-27998 |
| 14. |
Zhang, S.,
Han, J.,
Sells, M. A.,
Chernoff, J.,
Knaus, U. G.,
Ulevitch, R. J.,
and Bokoch, G. M.
(1995)
J. Biol. Chem.
270,
23934-23936 |
| 15. | Brown, J. L., Stowers, L., Baer, M., Trejo, J., Coughlin, S., and Chant, J. (1996) Curr. Biol. 6, 598-605[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Sells, M., Knaus, U., Bagrodia, S., Ambrose, D. M., Bokoch, G. M., and Chernoff, J. (1997) Curr. Biol. 7, 202-210 |
| 17. | Manser, E., Huang, H.-Y., Loo, T.-H., Chen, X.-Q., Dong, J.-M., Leung, T., and Lim, L. (1997) Mol. Cell. Biol. 17, 1129-1143[Abstract] |
| 18. |
Dharmawardhane, S.,
Sanders, L. C.,
Martin, S. S.,
Daniels, R. H.,
and Bokoch, G. M.
(1997)
J. Cell Biol.
138,
1265-1278 |
| 19. | Daniels, R. H., Hall, P. S., and Bokoch, G. M. (1998) EMBO J. 17, 754-764[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Adam, L.,
Vadlamundi, R.,
Kondapaka, S. B.,
Chernoff, J.,
Mendelsohn, J.,
and Kumar, R.
(1998)
J. Biol. Chem.
273,
28238-28246 |
| 21. |
Frost, J. A.,
Khokhlatchev, A.,
Stippec, S.,
White, M. A.,
and Cobb, M. H.
(1998)
J. Biol. Chem.
273,
28191-28198 |
| 22. | Tang, Y., Chen, Z., Ambrose, D., Liu, J., Gibbs, J. B., Chernoff, J., and Field, J. (1997) Mol. Cell. Biol. 17, 4454-4464[Abstract] |
| 23. | King, A. J., Sun, H., Diaz, B., Barnard, D., Miao, W., Bagrodia, S., and Marshall, M. S. (1998) Nature 396, 180-183[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Bagrodia, S.,
Taylor, S. J.,
Jordon, K. A.,
Van Aelst, L.,
and Cerione, R. A.
(1998)
J. Biol. Chem.
273,
23633-23636 |
| 25. | Manser, E., Loo, T.-H., Koh, C.-G., Zhao, Z.-S., Chen, X.-Q., Tan, L., Tan, I., Leung, T., and Lim, L. (1998) Mol. Cell 1, 183-192[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Oh, W. K., Yoo, J. C., Jo, D., Song, Y. H., Kim, M. G., and Park, D. (1997) Biochem. Biophys. Res. Commun. 235, 794-798[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Premont, R. T.,
Claing, A.,
Vitale, N.,
Freeman, J. L.,
Pitcher, J. A.,
Patton, W. A.,
Moss, J.,
Vaughan, M.,
and Lefkowitz, R. J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14082-14087 |
| 28. |
Chen, H. C.,
Appeddu, P. A.,
Isoda, H.,
and Guan, J. L.
(1996)
J. Biol. Chem.
271,
26329-26334 |
| 29. |
Bagrodia, S.,
Taylor, S. J.,
Creasy, C. L.,
Chernoff, J.,
and Cerione, R. A.
(1995)
J. Biol. Chem.
270,
22731-22737 |
| 30. | Hart, M. J., Eva, A., Evans, T., Aaronson, S. A., and Cerione, R. A. (1991) Nature 354, 311-314[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Michiels, F., Habets, G. G., Stam, J. C., van der Kammen, R. A., and Collard, J. G. (1995) Nature 375, 338-340[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Han, J.,
Luby-Phelps, K.,
Das, B.,
Shu, X.,
Xia, Y.,
Mosteller, R. D.,
Krishna, U. M.,
Falck, J. R.,
White, M. A.,
and Broek, D.
(1998)
Science
279,
558-560 |
| 33. |
Zhang, C.,
Cavenagh, M. M.,
and Kahn, R. A.
(1998)
J. Biol. Chem.
273,
19792-19796 |
| 34. |
Brown, M. T.,
Andrade, J.,
Radhakrishna, H.,
Donaldson, J. G.,
Cooper, J. A.,
and Randazzo, P. A.
(1998)
Mol. Cell. Biol.
18,
7038-7051 |
| 35. |
Cukierman, E.,
Huber, I.,
Rotman, M.,
and Cassel, D.
(1995)
Science
270,
1999-2002 |
| 36. |
Poon, P. P.,
Wang, X.,
Rotman, M.,
Huber, I.,
Cukierman, E.,
Cassel, D.,
Singer, R. A.,
and Johnston, G. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10074-10077 |
| 37. |
Hammonds-Odie, L. P.,
Jackson, T. R.,
Profit, A. A.,
Blader, I. J.,
Turck, C. W.,
Prestwich, G. D.,
and Theibert, A. B.
(1996)
J. Biol. Chem.
271,
18859-18868 |
| 38. | Drechsel, D. N., Hyman, A. A., Hall, A., and Glotzer, M. (1997) Curr. Biol. 7, 12-23[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Tjandra, H., Compton, J., and Kellogg, D. (1998) Curr. Biol. 8, 991-1000[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Cvrckova, F.,
De Virgilio, C.,
Manser, E.,
Pringle, J. R.,
and Nasmyth, K.
(1995)
Genes Dev.
9,
1817-1830 |
| 41. | Benton, B. K., Tinkelenberg, A., Gonzalez, I., and Cross, F. R. (1997) Mol. Cell. Biol. 17, 5067-5076[Abstract] |
| 42. | Guan, J.-L. (1997) Int. J. Biochem. Cell Biol. 29, 1085-1096[CrossRef][Medline] [Order article via Infotrieve] |
| 43. |
Price, L. S.,
Leng, J.,
Schwartz, M. A.,
and Bokoch, G. M.
(1998)
Mol. Biol. Cell
9,
1863-1871 |
| 44. | Nikolic, M., Chou, M. M., Lu, W., Mayer, B. J., and Tsai, L.-H. (1998) Nature 395, 194-198[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Turner, C. E., Brown, M. C., Perrotta, J. A., Riedy, M. C., Nikolopoulos, S. N., McDonald, A. R., Bagrodia, S., Thomas, S., and Leventhal, P. S. (1999) J. Cell Biol. 45, 851-863 |
This article has been cited by other articles:
![]() |
Z. M. Zhang, J. A. Simmerman, C. D. Guibao, and J. J. Zheng GIT1 Paxillin-binding Domain Is a Four-helix Bundle, and It Binds to Both Paxillin LD2 and LD4 Motifs J. Biol. Chem., July 4, 2008; 283(27): 18685 - 18693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chahdi and A. Sorokin Protein Kinase A-Dependent Phosphorylation Modulates {beta}1Pix Guanine Nucleotide Exchange Factor Activity through 14-3-3{beta} Binding Mol. Cell. Biol., March 1, 2008; 28(5): 1679 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Janz, T. P. Sakmar, and K. C. Min A Novel Interaction between Atrophin-interacting Protein 4 and beta-p21-activated Kinase-interactive Exchange Factor Is Mediated by an SH3 Domain J. Biol. Chem., September 28, 2007; 282(39): 28893 - 28903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sheehan, Y. Ke, and R. J. Solaro p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R963 - R973. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stockton, J. Reutershan, D. Scott, J. Sanders, K. Ley, and M. A. Schwartz Induction of Vascular Permeability: betaPIX and GIT1 Scaffold the Activation of Extracellular Signal-regulated Kinase by PAK Mol. Biol. Cell, June 1, 2007; 18(6): 2346 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Gerthoffer Mechanisms of Vascular Smooth Muscle Cell Migration Circ. Res., March 16, 2007; 100(5): 607 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Webb, H. Zhang, D. Majumdar, and A. F. Horwitz {alpha}5 Integrin Signaling Regulates the Formation of Spines and Synapses in Hippocampal Neurons J. Biol. Chem., March 9, 2007; 282(10): 6929 - 6935. [Abstract] [Full Text] [PDF] |
||||